Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 7,513 articles

Articles by Daniel Marsh

MarineMax Jumps 46% on $53/Share Safe Harbor Takeover Deal
Markets

MarineMax Jumps 46% on $53/Share Safe Harbor Takeover Deal

MarineMax (HZO) soars 46% after Safe Harbor agrees to buy the company for $53 per share in cash, a 48.5% premium to Friday's close. The deal spread narrows to 1.75%.

HZO
Microsoft Shares Climb as Bernstein Boosts Price Target on Disciplined Data-Center Spending
Analysis

Microsoft Shares Climb as Bernstein Boosts Price Target on Disciplined Data-Center Spending

Microsoft shares advanced Monday after Bernstein raised its price target to $660, citing disciplined data-center growth and strong backlog, even as free cash flow declined.

MSFT NVDA GOOGL AMZN META
S&P 500 Steadies Near Record as Oil Rally Highlights Funding Gap
Markets

S&P 500 Steadies Near Record as Oil Rally Highlights Funding Gap

U.S. stocks held near record highs Monday as oil jumped on Hormuz concerns, but a funding divide emerged between cash-rich firms and those issuing new equity.

SPY BRK.B INTC JPM HPE AAPL AMAT CSCO CRWV USO GLD
Varex Imaging Soars 48% on Teledyne's $1.1B Cash Acquisition Offer
Markets

Varex Imaging Soars 48% on Teledyne's $1.1B Cash Acquisition Offer

Varex Imaging (VREX) surged 48% in premarket trading after Teledyne (TDY) announced a $1.1 billion cash acquisition at $18.90 per share, a 52% premium.

VREX TDY
Intel's $15B Share Sale to Fund Capex, Dilute Stock by ~3%
Markets

Intel's $15B Share Sale to Fund Capex, Dilute Stock by ~3%

Intel (INTC) announced a $15 billion stock offering, diluting shares by ~3% to fund capital spending. Shares fell 3% premarket.

INTC TSM
Palantir Deal: USA TODAY's Data Bet Faces Tough Test
Analysis

Palantir Deal: USA TODAY's Data Bet Faces Tough Test

USA TODAY's new Palantir partnership aims to turn data into dollars, but a 12% audience slump and heavy debt make it a high-stakes gamble.

TDAY PLTR FDS
Tenax Therapeutics Plunges 85% as Phase 3 Trial Misses Key Goals
Markets

Tenax Therapeutics Plunges 85% as Phase 3 Trial Misses Key Goals

Tenax Therapeutics (TENX) shares plummeted 85% premarket after its Phase 3 LEVEL trial failed to meet primary endpoints, erasing $425 million in market cap.

TENX
Oklo's Rally Pushes Valuation to $9B Despite Early-Stage Revenue
Analysis

Oklo's Rally Pushes Valuation to $9B Despite Early-Stage Revenue

Oklo's 14.8% Friday surge lifts its market cap to $9B, but Q2 revenue of $1.2M and a $73.2M operating loss highlight the gap between valuation and execution.

OKLO SMR LEU
Jin Medical Shares Double Premarket After Share Count Surge
Markets

Jin Medical Shares Double Premarket After Share Count Surge

Jin Medical (NASDAQ:ZJYL) shares nearly doubled premarket as a post-deal share restructuring expanded the share count tenfold, resetting the company's valuation.

ZJYL
Doximity Soars 33% on AI Hopes, Analysts Split
Analysis

Doximity Soars 33% on AI Hopes, Analysts Split

Doximity (DOCS) surged 33% on AI revenue optimism, adding $1.2B in market value, but Wells Fargo downgraded the stock, citing unproven monetization.

DOCS WFC PIPR
B2Gold's Mali Permit Sparks Rally; Q2 Cash Flow Concerns Overlooked
Markets

B2Gold's Mali Permit Sparks Rally; Q2 Cash Flow Concerns Overlooked

B2Gold's stock rallied sharply after Mali granted a key mining permit, shifting focus from Q2 cash flow to future production growth.

BTG GDX KGC EGO
Steakholder Foods Soars on Warrant Trigger, Dilution Risk Looms
Markets

Steakholder Foods Soars on Warrant Trigger, Dilution Risk Looms

Steakholder Foods shares skyrocketed 161.6% premarket after warrants became deeply in-the-money, but the rally highlights dilution risks and funding needs.